Who
Keith Kennedy
CFO & COO
Company insider
Files Form 4 as: CFO & COO, CareDx; COO / CFO, Veracyte; President and CEO, Mcg Capital.
In numbers
- Trades disclosed
- 83
- Buys
- 0
- Sells
- 8
- Bought
- $0
- Sold
- $4.2M
- Companies
- 3
- Companies where not an officer
- 0
- First trade
- 15 Mar 2012
- Last trade
- 1 Oct 2026
- Last filed
- 5 Oct 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 1 Oct 2026filed 5 Oct 2026 | CDNA CareDxDiagnostics & Labs | SEC FORM 4 Code F | $200K3,018 at $66.23 | filing |
| 12 Sep 2026filed 15 Sep 2026 | CDNA CareDxDiagnostics & Labs | SEC FORM 4 Code F | $430K8,220 at $52.37 | filing |
| 12 Sep 2026filed 15 Sep 2026 | CDNA CareDxDiagnostics & Labs | SEC FORM 4 Code F | $430K8,220 at $52.37 | filing |
| 1 Jul 2026filed 2 Jul 2026 | CDNA CareDxDiagnostics & Labs | SEC FORM 4 Code F | $86K2,930 at $29.25 | filing |
| 1 Jul 2026filed 2 Jul 2026 | CDNA CareDxDiagnostics & Labs | SEC FORM 4 Code F | $86K2,930 at $29.25 | filing |
| 20 Apr 2026filed 22 Apr 2026 | CDNA CareDxDiagnostics & Labs | SEC FORM 4 Code A | —24,134 at $0.00 | filing |
| 20 Apr 2026filed 22 Apr 2026 | CDNA CareDxDiagnostics & Labs | SEC FORM 4 Code A | —24,134 at $0.00 | filing |
| 1 Apr 2026filed 3 Apr 2026 | CDNA CareDxDiagnostics & Labs | SEC FORM 4 Code F | $210K11,725 at $17.87 | filing |
| 1 Apr 2026filed 3 Apr 2026 | CDNA CareDxDiagnostics & Labs | SEC FORM 4 Code F | $210K11,725 at $17.87 | filing |
| 2 Feb 2026filed 4 Feb 2026 | CDNA CareDxDiagnostics & Labs | SEC FORM 4 Code A | —60,000 at $0.00 | filing |
| 2 Feb 2026filed 4 Feb 2026 | CDNA CareDxDiagnostics & Labs | SEC FORM 4 Code A | —14,474 at $0.00 | filing |
| 2 Feb 2026filed 4 Feb 2026 | CDNA CareDxDiagnostics & Labs | SEC FORM 4 Code F | $95K4,644 at $20.42 | filing |
| 2 Feb 2026filed 4 Feb 2026 | CDNA CareDxDiagnostics & Labs | SEC FORM 4 Code A | —60,000 at $0.00 | filing |
| 2 Feb 2026filed 4 Feb 2026 | CDNA CareDxDiagnostics & Labs | SEC FORM 4 Code A | —14,474 at $0.00 | filing |
| 2 Feb 2026filed 4 Feb 2026 | CDNA CareDxDiagnostics & Labs | SEC FORM 4 Code F | $95K4,644 at $20.42 | filing |
| 12 Sep 2025filed 15 Sep 2025 | CDNA CareDxDiagnostics & Labs | SEC FORM 4 Code F | $108K7,987 at $13.53 | filing |
| 21 Mar 2025filed 25 Mar 2025 | CDNA CareDxDiagnostics & Labs | SEC FORM 4 Code A | —77,195 at $0.00 | filing |
| 12 Sep 2024filed 16 Sep 2024 | CDNA CareDxoption or derivative · Diagnostics & Labs | SEC FORM 4 Code A | —100,651 at $0.00 | filing |
| 12 Sep 2024filed 16 Sep 2024 | CDNA CareDxDiagnostics & Labs | SEC FORM 4 Code A | —70,101 at $0.00 | filing |
| 2 Mar 2021filed 4 Mar 2021 | VCYT VeracyteDiagnostics & Labs | SEC FORM 4 Code F | $359K5,783 at $62.15 | filing |
News
No headline names them, or the companies they trade most, lately.